A recent study in primary breast cancer patients demonstrated auto-antibodies against a panel of tumor associated antigens including p53 (24%), c-myc (13%), BRCA1 (8%), BRCA2 (34%), and MUC1 (20%) by ELISA [35]. Here, MUC1 is linked to breast cancer.